role misoprostol in opertaive hysteroscopy

comparison between oral and vaginal misoprostol as a method of cervical ripening before operative hysteroscopy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201502001022393

Enrollment

500

Registered

2015-02-01

Start date

2014-01-06

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fertility-female gynecology

Interventions

oral miso prostol

vaginal miso prostol

operative hysteroscopy

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: all females candidates for operative hysteroscopy

Exclusion criteria

Exclusion criteria: non fit for surgry

Design outcomes

Primary

Measure	Time frame
Time needed to dilate the cervix up to 10mm	—

Secondary

Measure	Time frame
Ease of dilatation ;Complications of the drugs	—

Countries

Egypt

Contacts

Public ContactMohamed Hamman Awad

m_oj_h@yahoo.com00201005034393

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Mar 8, 2026